There is no statistically significant difference in the individuals' LDL levels between the two groups. However, it is observed that there is no correlation between the LDL levels and the total plaque score, which goes against the expected notion. This insight suggests that although the process is slow, individuals in the groups are not trending towards worse health outcomes based on the given data.
Today, Paul has Dave Feldman on the podcast to discuss, in depth, a recent study that he conducted about LDL and cardiovascular risk and what this may mean for the future of medicine.
*Produced by Mountain Valley Media
00:03:30 The genesis of Dave’s most recent study
00:07:00 is FH a phenotype or genotype polygenetic vs monogenetic
00:22:30 Dave’s overall perspective while conducting studies
0:24:00 Diving into Dave Feldman’s most recent study: Does APOE-B cause atherosclerosis
00:42:30 How the medical community has received this study
00:46:30 Do credentials matter?
00:58:30 Thoughts on Statins
01:04:45 What alters lipid levels
01:13:30 Connect with Dave
References:
Twitter: @realdavefeldman
Instagram: @realdavefeldman
Youtube: youtube.com/@realdavefeldman
https://citizensciencefoundation.org/